I am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health. I have master’s degrees in Biological Natural Sciences and the History and Philosophy of Science from Downing College, Cambridge University. Follow me on Twitter @theroberthart or get in touch at [email protected]
Sanofi and GlaxoSmithKline are hoping to launch their latest Covid vaccine later this year after trials found it to be particularly effective against the omicron variant, promising news for the pharmaceutical giants as they push to make up lost ground and capture part of the maturing coronavirus vaccine market.
Among adults who had already been infected with Covid, the shot was 75% effective against symptomatic infection, Sanofi said, citing its trial of more than 13,000 people. The vaccine was particularly effective at protecting against omicron infections, Sanofi said, 72% when used as a primary vaccine and 93% when used in those who have already had Covid.
The results, particularly the strong protection among those who have already been infected with Covid, complement findings from the companies’ trials testing the shot as a boosterThomas Triomphe, executive vice president at Sanofi, said the findings underscore the value of the company’s beta-based booster in a world where most people have been infected with Covid at some point, adding that the companies look forward to completing their submissions to regulators to get the shot approved.
Roger Connor, president of GSK Vaccines, said he hopes the shot will be available “later this year” and believes the vaccine has the “potential to make an important contribution to public health” as the pandemic continues to evolve.The early race to develop Covid-19 vaccines was dominated by new technology and, excluding Pfizer, which partnered with Germany’s BioNTech to make its shot, did not include any of the world’s.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
CDC advisers vote to recommend Moderna's COVID vaccine for adolescentsThe CDC's outside vaccine advisers voted unanimously to expand their recommendations for Moderna's COVID-19 vaccine to virtually all ages of children, adding the first alternative to Pfizer's shots for millions of adolescents and school-age kids.
Les mer »
900 places in LA County offering COVID vaccine for kids under 5More than 103,000 vaccine doses have been delivered to Los Angeles County vaccination sites, children's hospitals, pharmacies and pediatricians.
Les mer »
Publix Not Offering COVID Vaccine to Children Under 5Though the federal government recently authorized the COVID-19 vaccine for children under 5, Publix supermarkets will not offer the vaccine to children in that age group.
Les mer »
MCHD beginning to administer COVID-19 vaccine for infantsThe CDC recommended the COVID-19 vaccine for infants, dropping the age to 6 months.
Les mer »
CDC panel recommends Moderna two-dose Covid vaccine for kids ages 6 to 17CDC Director Dr. Rochelle Walensky is expected to sign off on the recommendation later Thursday,.
Les mer »
Emmy Rossum shares photo of 1-year-old daughter getting COVID vaccine“An exciting day we’ve waited a long time for!” the “Shameless” alum captioned a picture of the toddler sporting a silver Band-Aid via Instagram.
Les mer »